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Abstract
Background: Kato-Katz examination of stool smears is the field-standard method for detecting Schistosoma mansoni
infection. However, Kato-Katz misses many active infections, especially of light intensity. Point-of-care circulating
cathodic antigen (CCA) is an alternative field diagnostic that is more sensitive than Kato-Katz when intensity is low, but
interpretation of CCA-trace results is unclear. To evaluate trace results, we tested urine and stool specimens from 398
pupils from eight schools in Burundi using four approaches: two in Burundi and two in a laboratory in Leiden, the
Netherlands. In Burundi, we used Kato-Katz and point-of-care CCA (CCAB). In Leiden, we repeated the CCA (CCAL) and
also used Up-Converting Phosphor Circulating Anodic Antigen (CAA).
Methods: We applied Bayesian latent class analyses (LCA), first considering CCA traces as negative and then as positive.
We used the LCA output to estimate validity of the prevalence estimates of each test in comparison to the population-
level infection prevalence and estimated the proportion of trace results that were likely true positives.
Results: Kato-Katz yielded the lowest prevalence (6.8%), and CCAB with trace considered positive yielded the highest
(53.5%). There were many more trace results recorded by CCA in Burundi (32.4%) than in Leiden (2.3%). Estimated
prevalence with CAA was 46.5%. LCA indicated that Kato-Katz had the lowest sensitivity: 15.9% [Bayesian Credible
Interval (BCI): 9.2–23.5%] with CCA-trace considered negative and 15.0% with trace as positive (BCI: 9.6–21.4%), implying
that Kato-Katz missed approximately 85% of infections. CCAB underestimated disease prevalence when trace was
considered negative and overestimated disease prevalence when trace was considered positive, by approximately 12
percentage points each way, and CAA overestimated prevalence in both models. Our results suggest that approximately
52.2% (BCI: 37.8–5.8%) of the CCAB trace readings were true infections.
Conclusions: Whether measured in the laboratory or the field, CCA outperformed Kato-Katz at the low infection
intensities in Burundi. CCA with trace as negative likely missed many infections, whereas CCA with trace as positive
overestimated prevalence. In the absence of a field-friendly gold standard diagnostic, the use of a variety of diagnostics
with differing properties will become increasingly important as programs move towards elimination of schistosomiasis.
It is clear that CCA is a valuable tool for the detection and mapping of S. mansoni infection in the field and CAA may
be a valuable field tool in the future.
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Background
The standard field method of detecting Schistosoma
mansoni is through Kato-Katz (KK) testing, in which pa-
tient stool samples are examined by microscopy for
parasite eggs [1, 2]. However, this method is well known
to miss some infections, especially those of light inten-
sity [3]. Consequently, KK-based surveys can signifi-
cantly underestimate local prevalence of infection,
especially when the average infection intensity is low
within the communities tested [4], and when Kato-Katz
sampling does not take place over a number of days.
The point-of-care circulating cathodic antigen (CCA)
test is a field diagnostic test for S. mansoni that detects
circulating antigen from intravascular Schistosoma adult
worms, which is excreted in the urine of infected people.
CCA testing has recently been accepted by the World
Health Organisation for use in programmatic ‘mapping’
in areas where S. mansoni is the only endemic Schisto-
soma species [5]. CCA testing has been shown to detect
a higher proportion of S. mansoni infections than KK
testing [6], especially where infection is present at low
intensities [4, 7], and the CCA test exhibits less day-to-
day variation than KK [8]. However, whether faint ‘trace’
results should be considered as negative or positive has
been questioned [9–11].
Circulating Anodic Antigen (CAA) is another Schisto-
soma antigen. The laboratory-based Up-Converting
Phosphor-Lateral Flow CAA assay can be used on serum
(or plasma) or urine [12, 13]. Testing for CAA is more
sensitive at lower intensities of infection than either KK
or CCA [14], and CAA performed on a 2 ml sample of
urine (UCAA2000) may potentially detect a single worm
pair [13, 15]. Testing for the CAA antigen is also highly
specific [16]. Data from low-endemic settings in Zanzi-
bar (Schistosoma haematobium [17]) and China (Schisto-
soma japonicum [18]) indicate that the percentage of
Schistosoma infected individuals as determined by
UCAA2000 testing may be an accurate measure of
prevalence of ongoing active infections.
Although the CAA test appears a potential candidate,
there yet is no generally accepted ‘gold standard’ test to
definitively categorise individuals as truly infected (posi-
tive) or truly uninfected (negative). Latent class analysis
(LCA) is a statistical technique commonly used to com-
pare the performance of diagnostic tests in the absence
of a gold standard test. It has been used in a number of
different fields, including tuberculosis [19], malaria [20],
veterinary biology [21] and schistosomiasis [17]. LCA
uses all available information to estimate the proportion
of true positives testing positive for each test (i.e. the
sensitivity of each test), the proportion of true negatives
testing negative for each test (i.e. the specificity of each
test), and the proportion of individuals truly positive in
the population (i.e. the infection prevalence within the
population), as reviewed in [22, 23]. Applying LCA
within a Bayesian framework enables straightforward as-
sessment of the prevalence estimates from each test by
comparing the distributions of estimated test and esti-
mated infection prevalence. Here we use LCA to com-
pare different diagnostic tests (Table 1) to assess the
performance of the CCA test in low intensity settings,
with particular focus on how to interpret trace results.
Burundi has had a national control programme for S.
mansoni since 2008, in which school-age children are
treated with praziquantel during the nation’s annual ma-
ternal health weeks [24, 25]. In 2014, Burundi undertook
a mapping exercise, visiting 347 schools throughout the
country, testing 50 children within each school using the
CCA test [26], with the expectation that repeated rounds
of treatment would have lowered S. mansoni prevalence.
One of the aims of the remapping study was to assess
the suitability of Burundi for an elimination project by
the Schistosomiasis Consortium for Operational Re-
search and Evaluation (SCORE; https://score.uga.edu/).
As shown in Ortu, Ndayishimiye et al. [26], prevalence
of S. mansoni by CCA performed in Burundi (CCAB)
was 13.5% if ‘trace’ readings were considered negative
(CCABtn), rising to 42.8% when ‘trace’ readings were
considered positive (CCABtp). Concurrently, KK tests
were performed in 170 of these 347 schools to assess soil
transmitted helminths and S. mansoni infections. Within
these 170 schools, prevalence of S. mansoni by KK was
1.5% and prevalence by CCAB was 10.9% when ‘trace’
was considered negative, rising to 41.3% when ‘trace’
was considered positive. Of the children who were tested
by KK, only 1 one out of 8482 (0.01%) was heavily in-
fected according to WHO guidelines (i.e. having ≥ 400
eggs per gram (epg) of stool [1]), and 18 children
(0.21%) were assessed as moderately infected (100–399
epg). The remaining KK egg-positive children had light
intensity infections (1–99 epg). No children tested posi-
tive by KK in 84% of schools tested; the corresponding
figures for CCA were 18% when trace was considered
negative and just 2.4% when trace was considered
positive.
Subsequently, urine samples from eight purposively se-
lected schools were sent to Leiden University Medical
Center in the Netherlands, where they were tested again
using CCA cassettes from the same batch as was used in
Burundi, and by the CAA assay. The present LCA ana-
lysis uses the test results from these eight more inten-
sively studied schools with the following aims: (i) To
assess the sensitivity and specificity of four test results:
KK egg detection performed in Burundi, CAA per-
formed in Leiden, and CCA performed independently in
both Burundi (CCAB) and Leiden (CCAL). For the latter
CCA tests, we also compared outcomes when a ‘trace’
result was considered either negative (CCAtn) or
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positive (CCAtp). (ii) To evaluate which test gave preva-
lence estimates closest to the LCA-estimated infection
prevalence. (iii) To estimate the proportion of CCA trace
results that were true positives. (iv) To estimate test
properties and infection prevalence if the CAA positive
results were taken to be truly positive (i.e. assuming
CAA was 100% specific).
Methods
Data collection
The process used to select children for testing in the re-
mapping survey has been explained in detail in Ortu et
al. [26], and will only be briefly discussed here. We di-
vided Burundi into five ‘ecological zones’ and deter-
mined the number of schools to be tested in each zone
based on historic data. Within each zone, schools to in-
clude in the study were selected randomly for testing
with CCA only, KK only, or both CCA and KK. In each
school, 50 children between 13 and 14 years of age
present at school on the testing day were randomly se-
lected for testing, with no reference to possible infection
status; if 50 children aged 13–14 years were not avail-
able, ‘top-up’ from between ages 12–16 was permitted,
with selection of the remaining children being random
with no reference to age or possible infection status. KK
microscopy was done on a single stool sample, for which
two separate slides were prepared and examined and the
number of eggs on each slide recorded. CCA testing was
performed on a single urine sample taken on the same
day as the stool collection and scored on a five-point
scale: negative, trace, positive 1, positive 2, and positive
3. Residual urine from sampled children in all schools
was stored at -20 °C for potential analysis in Leiden.
CCA data was available for 347 schools, with 170 of
these schools also having KK data.
Following review of the remapping study results (see
introduction), eight schools were purposively selected
from among the 170 schools with both KK and CCA re-
sults to have their stored urine samples sent to Leiden
for confirmatory CCA and CAA testing. The sample size
of eight schools (approximately 400 pupils) was driven
by cost considerations. Only schools that were tested
using both CCA and KK (170 schools) were eligible for
selection to be sent to Leiden so that each child could
be assessed with all four tests. Random sampling of
schools was not felt to be appropriate as only 16% of the
170 schools [26] had at least one child positive by KK,
and consequently there was a risk that the KK data
would not be informative in subsequent analyses. How-
ever, simply choosing the eight schools with the highest
prevalence by KK (> 10% prevalence) would clearly also
not be appropriate as the results would not be represen-
tative of the population. Additionally, much of the focus
of discussion around the field results was related to the
large number of trace CCA results obtained and there
was a desire to investigate these further. Given the above
considerations, schools were then selected following re-
view of the data that had sufficient numbers of urine
samples from children positive by KK, as well as from
children who were negative by KK but positive by
CCAB. Because assessment of trace results was a prior-
ity, efforts were made to include an adequate number of
children who had trace-positive CCA readings, where
‘sufficient’ and ‘adequate’ were determined by consensus
by the project team. The selected urine samples were
anonymised, blinded, and sent to Leiden by commercial
shipper, maintained at 4 °C throughout transit.
Upon arrival in Leiden, the specimens were stored at
-20 °C until testing. The CCA and CAA assays were run
independently by technicians blinded to the results ob-
tained in Burundi, and using the same batch of CCA
tests as used in Burundi. The CCA test was performed
as described by the manufacturer with one drop (40 μl)
of urine, and negative/trace/positive scores were based
Table 1 Description of the diagnostics assessed
Short code Diagnostic Where assessed Sample used Metric Definition of positive
KK Kato-Katz Schools in
Burundi
2 × 1/24th g slides
from a single stool
sample
Number of S. mansoni
eggs detectable by
visual microscopy
Any S. mansoni egg
found in either slide
CCABtn Point-of-care circulating
cathodic antigen
Schools in
Burundi (CCAB)
Urine sample Intensity of band
against reference
1/2/3
CCABtp Point-of-care circulating
cathodic antigen
Schools in
Burundi (CCAB)
Urine sample Intensity of band
against reference
trace/1/2/3
CCALtn Point-of-care circulating
cathodic antigen
Laboratory in
Leiden (CCAL)
Urine sample Intensity of band
against reference
1/2/3
CCALtp Point-of-care circulating
cathodic antigen
Laboratory in
Leiden (CCAL)
Urine sample Intensity of band
against reference
trace/1/2/3
CAA Up-converting
phosphor-lateral flow
circulating anodic
antigen
Laboratory in
Leiden
Urine sample Laboratory test
reader (strip scanner)
≥ 1 pg CAA/ml urine
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upon comparison with a reference cut-off sample. The
CAA assays were performed as described elsewhere
using 2 ml urine [13, 15, 27].
Determining sensitivity and specificity of each test
Data were analysed using LCA, with one model in which
a CCA trace-positive was considered as negative for S.
mansoni infection, and one in which it was considered
positive. The details of LCA are explained in many re-
cent publications (e.g. [22, 23]) and we will only describe
it briefly here. The first step in an LCA analysis is to cal-
culate the number of people with each test combination
(positive for all four tests, positive by KK but negative by
all other tests, etc.). Each test combination is then re-
lated to the sensitivity and specificity of each test, and
the infection prevalence in the population (the ‘latent
class’ of interest) using likelihood functions.
These likelihood functions relate the diagnostic test
parameters being estimated to the observed test results.
Given each individual’s assumed latent infection status,
each test correctly or incorrectly determines them to be
positive or negative. For truly positive individuals, the
probability of each test correctly determining them to be
positive is the sensitivity of the test, whereas for truly
negative individuals, the probability of each test correctly
determining them to be negative is the specificity of the
test, with the proportion of truly positive and truly nega-
tive being determined by the infection prevalence in the
population. The likelihood equation for each test result
combination has two components: the probability of
each test combination for truly positive individuals (a
function of the test sensitivities and the prevalence) and
the probability of each test combination for truly nega-
tive individuals (a function of test specificities and 1
minus the prevalence, representing the proportion of
uninfected people in the population). The likelihood
functions are then related to the observed test combina-
tions through a multinomial distribution. The likelihood
equations can be extended to incorporate covariance
terms between the sensitivities and specificities of differ-
ent tests, reflecting conditional non-independence of
tests, for instance when both tests perform better at de-
tecting high intensity infections than low intensity infec-
tions [28]. Additionally, LCA can be further extended to
incorporate different populations, which also allows for
greater degrees of freedom in the analysis [29].
We ran the analyses in a Bayesian Framework using
OpenBugs [30] through the R2OpenBugs package [31]
in R [32]. We used Beta priors on the sensitivity and
specificity of each test to restrict possible values to be-
tween 0 and 1 using the BetaBuster application [33],
with the strongest prior being placed on KK test specifi-
city (Table 2). The independent prevalence estimates in
each school each had a prior of a Beta distribution with
α = β = 1, which is equivalent to the uniform distribution
on the interval [0, 1]. We took each school to be a differ-
ent population and linked the likelihood functions to the
test combinations using the multinomial distribution.
See Additional file 1: Code S1 for the code used in the
analysis. We ran the models using three chains, each
with 1000 iterations, a thin of 25, and a burn-in of 100,
giving an output of 2700 iterations. (The OpenBugs iter-
ation parameter specifies the number of iterations after
thinning but before the burn-in. Consequently, each
chain returned 1000–100 = 900 iterations.) Convergence
of the models was assessed using Gelman diagnostics
[34], and the appropriateness of the model fit was
assessed by comparing observed test prevalence to the
denominator of the positive predictive value (PPV):
values of, for example, KK prevalence far above the ob-
served 6.8% indicated that the model had converged to a
local maximum rather than a global maximum. Conver-
gence to a local maximum happened more often when
multiple covariances were fitted in the model. This was
not an issue in our final model.
Covariances between each pair of tests were included
in the model: the covariance was added to the sensitivity
or specificity term when the test results were both posi-
tive or both negative and subtracted when the test re-
sults were different. We attempted to fit covariance
terms between all tests in the model but we ran into
convergence challenges (see above), presumably due to
the low number of samples in the analysis. Instead, we
removed some covariances by setting the parameter
values to zero in the model. We fitted covariances of
each separate pair of tests in turn and assessed the
Bayesian Deviance Information Criterion (DIC) of the
resultant models (Additional file 1: Table S1). We always
fitted covariances between both the sensitivity and speci-
ficity of the same tests, and uniform priors were speci-
fied for the covariances, with each covariance being
bounded between zero and an upper limit such that the
relevant term containing the covariance could not go
above one. Following the single covariance terms model,
we then tested whether the two models with the lowest
DIC gave a lower value when both covariance terms
were fitted in the model. We also attempted to fit trace
negative and trace positive outcomes in a single model
(through specifying trace positive to be the same or
more sensitive and the same or less specific than trace
negative) but this led to some parameter values becom-
ing fixed at the boundary values of zero or one resulting
in a zero estimate of error. We tested the sensitivity of
the final model to the choice of priors by replacing, in
turn, the prior for the sensitivity or specificity by the
uniform distribution (Beta(1, 1)), and also by replacing
priors for all sensitivities and specificities by Beta(1, 1) in
the same model.
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Comparing estimated test and estimated infection
prevalence
One of the advantages of analysis within a Bayesian
framework is that the posterior distribution can easily be
used to calculate the distribution of ancillary variables
from the different iterations. We calculated the esti-
mated infection prevalence in the population using a
weighted average (weighted for the number of pupils
within each school) of the estimated infection prevalence
from each school.
We then compared the estimated infection prevalence
with each test prevalence by simulating an error distri-
bution around each observed test prevalence. We ob-
tained a distribution of the number of children testing
positive for each school and test by sampling 2700 times
(once for each iteration from the posterior distribution)
from a binomial distribution with parameters n equal to
the number of children tested in the focal school (49 or
50) and p equal to the proportion of children testing
positive in the focal school using the focal test. An over-
all estimate of prevalence by each test was then obtained
by summing the simulated number of positive children
across all schools and dividing by the total number of
children tested. Estimated infection prevalence and esti-
mated test prevalence were then compared using sub-
traction on the 2700 iterations of each parameter.
Estimating the proportion of trace results that were truly
positive
The PPV of a test estimates the probability that an indi-
vidual testing positive is truly positive. The PPV for test i
can be calculated using the equation:
PPV i ¼ prev  Seiprev  Sei þ 1−prevð Þ  1−Spið Þ
As much of the discussion around trace CCA results
have focused on the proportion of trace results that are
truly positive, we then used the output from both
models together to estimate the PPV of the trace results
alone using the equation:
PPV trace ¼
prevtrace pos  PPV trace pos−prevtrace neg  PPV trace neg
prevtrace pos−prevtrace neg
where PPVtrace_neg and PPVtrace_pos denotes the PPV
when traces were considered negative and positive re-
spectively, calculated using the equation above, and pre-
vtrace_neg and prevtrace_pos denotes the prevalence
estimates obtained from the LCA when traces were con-
sidered negative and positive, respectively.
Estimating test properties when specificity of CAA fixed
at 100%
We re-ran all of the analyses above with the specificity
of CAA fixed to 100% to determine test properties if it
was assumed that all of the CAA positive results were
true positives.
Results
Prevalence estimates and test combinations
The dataset consisted of data from 398 pupils from eight
different schools, with each child having four separate
test results, and six separate test readings after inclusion
of the two interpretations of each CCA result.
There was an almost eight-fold difference between the
highest and lowest prevalence estimates by the studied
tests for S. mansoni, ranging from 6.8% by KK to 53.5%
by CCABtp (Table 3, Additional file 1: Table S2 for
prevalence figures in each school). The most striking dif-
ference between CCA results in Burundi and Leiden
were the number of trace results recorded: almost
one-third (32.4%) of children tested in Burundi were
recorded as trace by CCA compared to only 2.3% in
Leiden. Of the nine pupils assessed as trace by CCAL,
eight were also trace in Burundi, and one was assessed
Table 2 Details of informative priors used in Bayesian latent class analysis for test parameters. Alpha and Beta denote the
parameters of the beta distribution and the mean, standard deviation (SD), 95% greater than and mode indicate the properties of
the distribution with the given parameters. The sum of Alpha and Beta is often known as the ‘sample size equivalent’ and the effect
of the prior can be thought of as adding alpha + beta samples to the analysis, with alpha samples being positive
Parameter Test Alpha Beta Mean
(%)
SD
(%)
95% greater
than (%)
Mode
(%)
Sample size
equivalent
Sensitivity KK 1.43 1.29 53 26 10 60 2.72
CCAB 3.05 1.51 53 26 30 80 4.56
CCAL 3.05 1.51 53 26 30 80 4.56
CAA 3.05 1.51 53 26 30 80 4.56
Specificity KK 21.2 2.06 91 6 80 95 23.26
CCAB 5.38 1.49 53 26 50 90 6.87
CCAL 5.38 1.49 53 26 50 90 6.87
CAA 5.38 1.49 53 26 50 90 6.87
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as positive 1 (Additional file 1: Table S3). Of the 129 pupils
assessed as trace by CCAB, 88 were negative by CCAL,
eight were trace, 31 were positive 1, two were positive 2
and none were positive 3. When children assessed as trace
in either Burundi or Leiden were removed from the re-
sults, 84% of the remaining test results were the identical
by both CCAB and CCAL, and 97% were within one point
on the marking scale.
LCA uses the test result combinations for each studied
individual to estimate the diagnostic performance of
each included test. The most frequent test combination
was negative by all four tests (35.7%; Fig. 1). In contrast,
positive by all four tests was only the seventh most com-
mon test combination (3.8%). The test combinations be-
tween 1st and 7th most common were all negative by
Kato-Katz but trace or positive by one or more antigen
tests. See Additional file 1: Table S4 for all test combina-
tions, overall and split by school. Of the 27 children who
were positive by KK, 16 (59%) were also positive by
CCAB when trace was considered negative, rising to 22
(81%) when trace was considered positive; CCAL was
positive in 21 of the 27 (78%); since no KK-positive child
had a CCAL trace result, this was true whether trace
was considered negative or positive. CAA was positive
for 24 of the 27 KK-positive children (89%). A total of
185 children were assessed to be positive by CAA. Of
these 185 children, fewer were positive by CCAB (41%)
than CCAL (56%) when trace was negative, but more
were positive by CCAB (79%) than CCAL (59%) when
trace was positive. Additionally, of the 213 children
negative by CAA, fewer were positive by CCAB than
CCAL both when trace was negative (proportion of
CAA negative children positive, CAAB: 4%, CAAL: 35%)
and when trace was positive (proportion of CAA nega-
tive children positive, CAAB: 31%, CAAL: 36%).
Sensitivity and specificity estimates
By far the lowest sensitivity estimate was for KK, at
15.9%, with Bayesian Credible Interval (BCI) 9.2–23.5%
when CCA trace readings were considered negative and
15.0% (BCI: 9.6–21.4%) when CCA trace readings were
considered positive (Table 4, Fig. 2), implying that KK
failed to detect approximately 85% of infections in the
study population. The only tests with sensitivity
Table 3 Summary statistics and prevalence by different
diagnostic tests in eight schools in Burundi. Samples from each
child were tested using four different diagnostics: Kato-Katz per-
formed in Burundi, CCA performed in Burundi, CCA performed
in Leiden and CAA performed in Leiden. Additionally, CCA re-
sults were considered both with trace results as negative and
with trace results positive
Test Prevalence (%)
(by school range)a
Kato-Katz in Burundi (KK) 6.8 (0–20)
CCA in Burundi: trace-negative (CCABtn) 21.1 (0.0–44.0)
CCA in Burundi: trace-positive (CCABtp) 53.5 (12.0–90.0)
CCA in Leiden: trace-negative (CCALtn) 28.4 (0.0–60.0)
CCA in Leiden: trace-positive (CCALtp) 30.7 (0.0–64.0)
CAA in Leiden (CAA) 46.5 (6.0–78.0)
aData from 398 pupils from 8 schools. Between 48% and 59% of children
tested within each school were female, with the overall average being 51%.
The mean age of children was 13.1 years with an associated standard
deviation of 0.67 years
Fig. 1 Combinations of Schistosoma mansoni diagnostic test results from 398 pupils in Burundi. The graph shows the percentage of pupils with
each test result combination for those test combinations with at least 10 pupils. The most frequent test combination was negative by all four
tests. Abbreviations: Neg, negative; tr, trace; pos, positive. All other abbreviations as defined in Table 1
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estimates above 90% were CAA (both in the ‘CCA-
trace-is-negative’ and the ‘CCA-trace-is-positive’ models)
and CCABtp. However, the CAA and CCABtp tests also
had the lowest specificity estimates, whereas all other
tests had specificity estimates of at least 97%.
Considering CCA trace as positive had a large impact
on the sensitivity and specificity of CCAB, but less im-
pact for CCAL, presumably due to the lower number of
traces in Leiden (Table 4, Fig. 2). The sensitivity and spe-
cificity of KK was comparable when trace was consid-
ered both as negative and as positive, as was the
sensitivity of CAA. However, considering trace as posi-
tive led to a substantial increase in the estimate of CAA
specificity, from 74.6% (BCI: 68.3–81.2%) when trace
was considered negative, to 85.3% (BCI: 79.3–91.1%)
when trace was considered positive. See Additional file
1: Table S1 for DICs of the models fitted with different
covariance terms and Additional file 1: Table S5 for 95%
BCIs of differences between estimates from the trace
negative and trace positive models.
Impact of the choice of priors on the estimates obtained
from the LCA
The final model showed very little sensitivity to the
choice of priors, even when the priors for all sensitivities
and specificities were set to the uniform distribution
(Additional file 1: Figure S1). This implies that the ana-
lyses were very robust to the choice of priors.
Comparison of estimated test and estimated infection
prevalence
The estimated infection prevalence was 33.1% (BCI:
27.9–39.1%; Table 5; Fig. 3) in the model with trace
considered negative, and 40.8% (BCI: 35.5–46,5%) in
the model with trace considered positive, although
the 95% BCI of difference between the infection
prevalence from each model marginally straddled zero
(Additional file 1: Table S5). No observed test preva-
lence was convincingly close to the estimated infec-
tion prevalence, but KK was clearly the worst
performing test, underestimating prevalence by 26
percentage points when CCA trace was considered
negative (BCI: -32.3– -20.7%) and 34 percentage
points when CCA trace was considered positive (BCI:
-40.0– -28.0%). CCAB underestimated infection preva-
lence when trace results were considered negative,
but overestimated infection prevalence when trace
was considered positive, by approximately 12 percent-
age points each way. CCAL showed a similar pattern,
but with much lower amounts of over- and underesti-
mation, and the BCI’s in the model when trace was
considered negative suggested that this difference was
not significant (overestimation = 4.6%, BCI: -11.9–
-1.9%). Both models suggested that CAA overesti-
mated prevalence, although the BCI’s marginally
straddled zero in the model when CCA trace was
considered positive (overestimation = 5.7%, BCI: -1.4–
12.4%).
Proportion of trace results truly positive
Our model suggests that 95.8% (BCI: 89.4–99.6%) of
the positive CCAB results were truly infection posi-
tive when CCA trace was considered as negative
(Table 4, Fig. 4). However, when CCA trace was con-
sidered as positive, 69.4% (BCI: 61.7–77.1%) of the
positive CCA results were estimated to be truly posi-
tive. Combining these results suggested that 52.2%
(BCI: 37.8–65.8%) of the CCAB ‘trace’ results were
indeed true positive results, although the BCIs on this
estimate were relatively wide.
Table 4 Output from Bayesian LCA to estimate the sensitivity
and specificity of diagnostic tests. The mean estimate for each
parameter is shown, with 95% Bayesian Credible Intervals (BCI)
shown in parentheses. Analysis was performed separately for
CCA trace as negative (left) and CCA trace as positive (right).
The covariance terms inputted into each model were selected
by comparing the DIC’s of models with differing covariance
terms added (see Additional file 1: Table S1). The PPV of CCA
performed in Burundi was calculated using the equations
described in the methods
CCA trace
negative (%)
(95% BCI)
CCA trace
positive (%)
(95%BCI)
Sensitivity
Kato-Katz in Burundi 15.9 (9.2–23.5) 15.0 (9.6–21.4)
CCA in Burundi 61.1 (49.9–71.9) 91.5 (85.8–96.0)
CCA in Leiden 79.5 (67.7–89.4) 72.0 (62.5–80.5)
CAA in Leiden 90.3 (84.5–95.0) 91.8 (85.0–96.9)
Covariance CCAL & CAA 0.6 (0.0–1.5)
Covariance CCAB & CCAL 0.3 (0.0–0.7)
Specificity
Kato-Katz in Burundi 97.1 (94.5–99.1) 97.5 (95.2–99.3)
CCA in Burundi 98.7 (96.6–99.9) 72.3 (65.6–78.7)
CCA in Leiden 97.3 (94.7–99.2) 96.8 (93.9–98.8)
CAA in Leiden 74.6 (68.3–81.2) 85.3 (79.3–91.1)
Covariance CCAL & CAA 0.4 (0.0–1.1)
Covariance CCAB & CCAL 0.3 (0.0–0.8)
PPV of CCA in Burundi
(95% BCI)
Trace as negative 95.8 (89.4–99.6)
Trace as positive 69.4 (61.7–7.1)
Trace results only 52.2 (37.8–5.8)
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Estimating test properties when specificity of CAA fixed
at 100%
We repeated the analyses above after fixing the speci-
ficity of CAA to 100%, to estimate the other tests’
properties if all the CAA positive results were indeed
true infections. The sensitivity estimates for all tests
were lower when CAA specificity was set at 100%,
than in the original analyses where CAA specificity
was allowed to vary. However, examination of the
95% BCI’s of the differences between models indicated
that only the changes in CCAB and CCAL sensitiv-
ities were significant. Specificity estimates were com-
parable between analyses, and all 95% BCI’s of the
differences between models straddled zero (see Add-
itional file 1: Table S6 for parameter estimates and
Additional file 1: Table S7 for BCI’s of differences be-
tween parameter estimates).
The estimated infection prevalence from these
models was substantially higher than when specificity
of CAA was allowed to vary, but strikingly similar
whether trace was considered as negative or positive, at
53.4% (BCI: 48.5–58.3%; Fig. 3; Additional file 1: Tables
S6 and S7) when CCA trace was considered negative
and 52.3% (BCI: 47.4–57.2%) when CCA trace was con-
sidered positive. In the model with trace considered
negative, all tests significantly underestimated infection
prevalence, but in the model with trace as positive,
CCAB and CAA gave prevalence estimates not signifi-
cantly different from estimated infection prevalence
(Additional file 1: Table S8).
Discussion
With data from 398 children, we used LCA to assess the
performance of three different assays for S. mansoni
Fig. 2 Distribution of sensitivity (left) and specificity (right) of the four diagnostic tests assessed: Kato-Katz, CCA performed in Burundi, CCA
performed in Leiden and CAA. Analysis was performed separately for CCA trace as negative (blue) and CCA trace as positive (green). The
distribution was obtained by plotting the 2700 iterations outputted from the Bayesian LCA
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infection, with one assay being independently performed
in two different locations. We confirmed the long-
agreed low sensitivity of microscopic KK egg counts for
low intensity infections without multiple days of Kato-
Katz, and then quantified the higher test sensitivity of
both CCA and CAA antigen tests. We compared
estimated infection prevalence with that estimated using
each test’s results and demonstrated that CCA
performed much better in detecting infection than KK.
CAA showed very high sensitivity. Although it is
currently strictly a laboratory-based assay, it could be a
promising confirmatory test in the future.
We analysed the data using LCA in a Bayesian frame-
work. The use of LCA avoids having to make assump-
tions as to which test, or test combinations, perform as
a ‘gold standard’; that is, the best measure of prevalence
(as was done in two recent reviews [35, 36]). Rather, the
LCA combined all the available data to generate an esti-
mate of infection prevalence. Performing the analyses in
a Bayesian framework had two main advantages. First,
we could use a strong prior on the parameter we had
most confidence in, which was the specificity of KK
microscopy, as the visual detection of an egg indicates
actual infection unless laboratory/administrative error or
contamination has occurred. Indeed, the estimates of KK
specificity were above the mode of the Bayesian prior
values, suggesting that the data supported our assump-
tion, and this is further supported by the model being
robust to the choice of prior. Secondly, the added flexi-
bility from the Bayesian output enabled us to easily
compare estimated prevalence by the different assays to
estimated infection prevalence by LCA. Because national
control programs will typically measure prevalence rather
than each individual’s infection status, this approach
allowed us to assess test performance for way it will most
commonly be used in the field.
The sensitivity of KK was much lower than that of any
other test. Although this result was expected in an area
of low mean infection intensity [7], the magnitude by
which KK underestimated infection prevalence remained
striking, and the performance of the KK test is clearly
sub-optimal for programmes such as that of Burundi.
KK remains a valuable tool in areas of higher infection
intensity [7], where prevalence estimates are more con-
sistent with those based on CCA testing. Additionally,
KK remains a useful tool for concurrent detection of
soil-transmitted helminths. However, our data and ana-
lyses indicate that it should be used in concert with the
CCA assay if low S. mansoni intensity is expected.
CCA specificity assuming traces are negative was com-
parable to that of KK, but its estimated sensitivity was
much greater. Treating CCA trace as positive in Burundi
further increased the sensitivity of CCA, but at the cost
of reduced specificity. The PPV estimates we have calcu-
lated suggested that a substantial proportion of the CCA
trace results, around half but perhaps 35–65%, were in-
deed true infections. Consequently, prevalence estimated
using CCAB with trace as negative likely underestimated
infection prevalence, while CCAB with trace as positive
possibly overestimated infection prevalence. However, if
Table 5 The distribution of LCA-estimated disease and test prevalence from 398 pupils in 8 schools. Infection prevalence estimates
were calculated as a weighted average of the prevalence estimate in each school outputted from the Bayesian Latent Class Analysis
(weighted for number of pupils sampled in each school). The distributions of estimated test prevalences were simulated from the
observed prevalence using the binomial distribution. The estimated to infection prevalence gap shows the distribution of estimated
infection prevalence minus estimated test prevalence. Separate models were run when CCA trace was considered as negative (left)
or positive (right)
Trace negative (%) Trace positive (%)
Mean SD LBCI UBCI Mean SD LBCI UBCI
Infection prevalence 33.14 2.88 27.89 39.11 40.78 2.77 35.51 46.48
Estimated prevalence
Kato-Katz in Burundi 6.79 1.21 4.52 9.30 6.76 1.20 4.52 9.05
CCA in Burundi 21.15 1.95 17.34 24.87 53.58 2.30 49.00 58.04
CCA in Leiden 28.39 2.07 24.37 32.41 30.69 2.06 26.63 34.93
CAA in Leiden 46.50 2.22 42.21 50.89 46.46 2.23 42.21 50.75
Estimated - infection
prevalence
Kato-Katz in Burundi -26.35 3.11 -32.72 -20.69 -34.02 3.04 -39.97 -27.96
CCA in Burundi -11.99 3.51 -18.90 -5.31 12.80 3.56 5.63 19.44
CCA in Leiden -4.75 3.52 -11.90 1.91 -10.09 3.46 -16.92 -3.40
CAA in Leiden 13.36 3.66 6.06 20.41 5.68 3.49 -1.38 12.40
Abbreviations: SD standard deviation, LBCI lower Bayesian 95% credible interval, UBCI upper Bayesian 95% credible interval
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the CAA-positive results were indeed all true positives,
then CCAB with trace as positive may have accurately
reflected infection prevalence in the eight schools.
There is currently no field test to accurately determine
schistosomiasis prevalence in the population, i.e. there is
no ‘gold standard’ field diagnosis, but it is evident that
the CCA test performs better than KK in diagnosing S.
mansoni infection in low prevalence/low intensity
settings. Additionally, the relative ease of use of CCA
compared to KK means that CCA may be more suitable
for use in the community, perhaps in test and treat strat-
egies [4], especially given that the cost of individual
CCA tests is decreasing over time.
The sensitivity estimates of CAA were very high, above
90%, although the specificity of CAA was relatively low,
at 75% when trace was considered negative and 85%
when trace was considered positive. The high sensitivity
of CAA was consistent with the raw data, where CAA
detected the highest proportion of infections positive by
KK. However, the relatively low specificity estimate for
CAA was driven by children for whom CAA was the
only positive test. Thus, this low specificity could be a
result of false positives by CAA, with all other tests
being true negatives, or could result from CAA being
true positive while all other tests are false negatives. This
is an expected output from an LCA when only one test
indicates infection, unless a strong prior is indicated for
that test. Data from other studies [13, 16, 37] have indi-
cated very high specificity of CAA. Therefore, we re-ran
the analyses with CCA specificity fixed at 100%, which
resulted in lower sensitivity estimates for all tests, and
much lower estimates for CCAB and CCAL. These
results indicated that the prevalence estimates from
CCAB with trace as positive may indeed reflect infection
prevalence in the population.
The difference between CCA results in Burundi and
Leiden is striking, in particular the fewer number of
trace readings in Leiden. Low levels of within and
between observer variation in reading of CCA cassettes
has been observed in field evaluation [8]. However, this
study considered observers who were in the same loca-
tion and presumably trained together. Although teams
were provided with pictures of standard references, the
differences observed may have been due to between-
group differences in CCA interpretation, especially
around the trace results. That 98% of the trace results in
Burundi were assessed as within one scale point of trace
in Leiden, and that 84% of the non-trace results were
the same between Burundi and Leiden, suggests that the
differences may have been due to interpretation of trace
results. Efforts are ongoing to reduce variability in read-
ings by changing the cassette or developing a mobile
Fig. 3 Graphs of infection and test prevalence estimates from 398 pupils in 8 schools. Separate models were run with CCA trace considered as
negative (left) and positive (right), both from the original models (top) and models where the specificity of CAA was fixed to 100% (bottom).
Infection prevalence estimates were calculated as a weighted average of the prevalence estimate in each school outputted from the Bayesian
LCA (weighted for number of pupils sampled in each school). The distribution of estimated test prevalence was obtained by a weighted average
of the number of children infected in each school, simulated by drawing from a Binomial distribution with n equal to the number of children
tested in each school and p equal to the proportion of children positive by the focal test
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optical scanner or software to read cassettes. Addition-
ally, we cannot discount the possibility that transporta-
tion affected the urine samples, even though CCA is an
extremely stable carbohydrate and all storage and trans-
portation protocols were followed. Nevertheless, CCA
measured in both Burundi and Leiden performed sub-
stantially better at estimating prevalence than the
current alternative field diagnostic, KK. It remains to be
seen if high numbers of trace readings will be a common
feature of CCA tests in low-intensity settings but it is
clear that CCA outperforms Kato-Katz in these difficult
to assess areas. We recommend that CCA trace results
be explicitly recorded in the field to enable comparison
of prevalence estimates considering trace as negative
and as positive.
Although there is clearly a need for very large-scale
studies using many diagnostics, this study is a valuable
contribution to the literature, providing more knowledge
on the performance of CCA in low intensity settings.
The main strength of this study is the inclusion of the
CAA results to provide more information on each
individual’s infection status and to improve the robust-
ness of the model. Another important aspect of the
study is that it took place in a low-intensity setting;
many other CCA studies have taken place in higher in-
tensity settings. In Burundi, only 16% of schools had at
least one pupil testing positive by KK. The cost of CAA
laboratory testing in Leiden meant that samples from
only eight schools could be sent for CAA evaluation.
Consequently, there was a substantial chance that ran-
dom sampling of schools would lead to very little mean-
ingful data being available for the KK tests. Hence, the
decision was taken to purposively select the eight
schools, resulting in a prevalence by KK of 6.8% com-
pared to 1.5% across all 170 schools that were assessed
by both CCA and KK. Although purposive sampling
may induce some biases in the data, the prevalence by
KK in the selected schools was still low, giving us confi-
dence that the results presented here can be generalised
to low prevalence and intensity settings. The sample size
of 398 pupils is also perhaps why attempts to fit both
trace negative and trace positive results into a single
Fig. 4 Distribution of positive predictive values (PPV) of CCA performed in Burundi from a Bayesian LCA of 398 pupils in 8 schools when trace
was considered negative (top), positive (middle) and for traces only (bottom)
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model failed, as did attempts to fit multiple covariances
into the model a model with CCA, and we instead fitted
only the covariance term that resulted in the lowest
DIC. Although larger sample sizes were not possible be-
cause of the cost of processing CAA, the inclusion of
this extra test adds insight and robustness that would
not be possible from simply comparing the larger num-
ber of CCA and KK results obtained in the field, and
which are reported in detail elsewhere [26].
It is clear from these results that there is much more
residual S. mansoni infection in Burundi than KK indi-
cates [27], with the models suggesting infection preva-
lence of 33% when trace was negative and 41% when
trace was positive. The higher prevalence with trace as
positive is expected as there was more agreement
between tests when trace was considered positive.
However, these trace-positive infections are likely to be
of low intensity, and, although there may always be
morbidity associated with any Schistosoma infection
[38], the need to treat in areas where most positive
children are trace-positive for morbidity prevention
may be less acute than in areas with higher intensities
of infection. Even considering CCA trace as negative
would give prevalence estimates three to four times
higher than found by KK.
Conclusions
The appropriate tool to test for S. mansoni infection is
dependent on the stage of advancement of the control
program [39]. Both KK and CCA perform well when
average infection intensities are high, which is typical at
the beginning of morbidity control programs. Because of
its greater sensitivity, CCA is clearly more suitable for
established control programmes, as in Burundi, where
KK is likely to perform poorly, and as countries decide
to move towards Schistosoma elimination. CAA is an-
other available diagnostic tool, but it is currently expen-
sive and solely laboratory-based. In many diseases, it is
common to use a step-wise combination of diagnostics
to confirm diagnosis, and this is also likely to be true in
low-intensity schistosomiasis. It seems clear that CCA,
recently recommended by the WHO, is a useful compo-
nent of the diagnostic toolbox, particularly for mapping
and screening programmes, but it should not be seen as
the only tool. As schistosomiasis elimination pro-
grammes become more mature the number of tools will
hopefully increase, and CAA may also prove to be a
valuable field tool in the future. We would caution
against comparing new diagnostics or mapping tools
only against an imperfect standard test (either KK in the
case of S. mansoni or urine filtration in the case of S.
haematobium) when use of other means, such as LCA,
will yield more appropriate and reliable information
about relative diagnostic performance of better tests.
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